Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HSP70 Heat-Shock Proteins | 6 | 2023 | 393 | 1.600 |
Why?
|
Facial Transplantation | 5 | 2023 | 221 | 1.000 |
Why?
|
Molecular Chaperones | 6 | 2024 | 762 | 0.880 |
Why?
|
Graft Rejection | 12 | 2023 | 4499 | 0.860 |
Why?
|
Dendritic Cells | 6 | 2018 | 2747 | 0.740 |
Why?
|
Immunity, Humoral | 3 | 2022 | 605 | 0.680 |
Why?
|
Skin Transplantation | 2 | 2022 | 1098 | 0.640 |
Why?
|
Immunity, Innate | 4 | 2023 | 3081 | 0.620 |
Why?
|
Integrin alpha Chains | 1 | 2018 | 93 | 0.590 |
Why?
|
Chemokines | 1 | 2022 | 956 | 0.570 |
Why?
|
T-Lymphocytes | 7 | 2023 | 10261 | 0.550 |
Why?
|
Heat-Shock Proteins | 4 | 2024 | 791 | 0.490 |
Why?
|
Receptors, Scavenger | 3 | 2023 | 123 | 0.480 |
Why?
|
Kidney Transplantation | 6 | 2023 | 4270 | 0.470 |
Why?
|
Immunity, Cellular | 3 | 2022 | 1555 | 0.470 |
Why?
|
T-Lymphocytes, Regulatory | 9 | 2024 | 3111 | 0.440 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2013 | 26 | 0.440 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2013 | 102 | 0.420 |
Why?
|
Scavenger Receptors, Class F | 3 | 2020 | 16 | 0.410 |
Why?
|
Interleukin-2 | 4 | 2024 | 1896 | 0.410 |
Why?
|
Th1 Cells | 2 | 2018 | 1039 | 0.390 |
Why?
|
CD4-Positive T-Lymphocytes | 6 | 2021 | 4405 | 0.380 |
Why?
|
Melanoma, Experimental | 3 | 2014 | 558 | 0.370 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2018 | 1441 | 0.370 |
Why?
|
Interleukin-17 | 2 | 2020 | 921 | 0.360 |
Why?
|
Heart Transplantation | 2 | 2021 | 3310 | 0.360 |
Why?
|
Graft Survival | 3 | 2024 | 3890 | 0.350 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2010 | 305 | 0.320 |
Why?
|
Interferon-gamma | 3 | 2018 | 3160 | 0.320 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1892 | 0.310 |
Why?
|
Matrix Metalloproteinase 3 | 2 | 2019 | 139 | 0.310 |
Why?
|
Interleukin-10 | 5 | 2018 | 1183 | 0.300 |
Why?
|
Antigens, CD | 1 | 2018 | 4025 | 0.290 |
Why?
|
Mycoplasma hyopneumoniae | 2 | 2017 | 2 | 0.280 |
Why?
|
Respiratory Syncytial Virus Infections | 2 | 2020 | 365 | 0.230 |
Why?
|
Vaccines, Synthetic | 3 | 2022 | 621 | 0.230 |
Why?
|
Mice, Inbred C57BL | 15 | 2020 | 22332 | 0.220 |
Why?
|
Mice, Inbred BALB C | 6 | 2020 | 6220 | 0.210 |
Why?
|
Receptors, Purinergic P2X7 | 2 | 2013 | 86 | 0.200 |
Why?
|
Transplantation, Homologous | 5 | 2024 | 4860 | 0.200 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2022 | 422 | 0.200 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2022 | 385 | 0.190 |
Why?
|
STAT3 Transcription Factor | 2 | 2018 | 870 | 0.190 |
Why?
|
Lipopolysaccharides | 5 | 2022 | 2216 | 0.190 |
Why?
|
Purinergic P2Y Receptor Agonists | 1 | 2020 | 4 | 0.180 |
Why?
|
Chemokines, CC | 1 | 2022 | 285 | 0.180 |
Why?
|
Receptors, Purinergic P2Y2 | 1 | 2020 | 18 | 0.180 |
Why?
|
Mice | 19 | 2024 | 81819 | 0.170 |
Why?
|
Antibodies, Viral | 5 | 2023 | 3211 | 0.170 |
Why?
|
Scavenger Receptors, Class E | 1 | 2020 | 8 | 0.170 |
Why?
|
Macrophages | 4 | 2016 | 5772 | 0.170 |
Why?
|
Lectins, C-Type | 1 | 2023 | 592 | 0.160 |
Why?
|
Animals | 24 | 2024 | 168764 | 0.160 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2020 | 474 | 0.160 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2020 | 479 | 0.160 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2020 | 4348 | 0.150 |
Why?
|
Diet, Gluten-Free | 1 | 2021 | 285 | 0.150 |
Why?
|
Immunosuppressive Agents | 4 | 2022 | 4209 | 0.150 |
Why?
|
Phagocytes | 1 | 2020 | 292 | 0.150 |
Why?
|
Peptide Fragments | 1 | 2010 | 5125 | 0.150 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 152 | 0.150 |
Why?
|
Endocytosis | 2 | 2020 | 951 | 0.140 |
Why?
|
Dairy Products | 1 | 2021 | 491 | 0.140 |
Why?
|
Pneumonia of Swine, Mycoplasmal | 1 | 2017 | 2 | 0.140 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2018 | 168 | 0.140 |
Why?
|
Nephrotic Syndrome | 1 | 2021 | 380 | 0.140 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2018 | 122 | 0.140 |
Why?
|
Skin | 2 | 2022 | 4489 | 0.140 |
Why?
|
Mammals | 1 | 2023 | 1125 | 0.140 |
Why?
|
Viral Matrix Proteins | 1 | 2018 | 192 | 0.140 |
Why?
|
Antigens, Ly | 1 | 2018 | 296 | 0.140 |
Why?
|
Toll-Like Receptor 2 | 2 | 2013 | 348 | 0.140 |
Why?
|
Toll-Like Receptor 4 | 2 | 2015 | 586 | 0.130 |
Why?
|
Microglia | 2 | 2022 | 1372 | 0.130 |
Why?
|
Receptor, Notch1 | 1 | 2019 | 517 | 0.130 |
Why?
|
Organ Transplantation | 2 | 2024 | 1174 | 0.130 |
Why?
|
Mycoplasma | 1 | 2016 | 144 | 0.130 |
Why?
|
Granzymes | 1 | 2017 | 278 | 0.130 |
Why?
|
Membrane Proteins | 3 | 2018 | 7851 | 0.130 |
Why?
|
Critical Illness | 3 | 2013 | 2744 | 0.120 |
Why?
|
Bacterial Proteins | 4 | 2017 | 3837 | 0.120 |
Why?
|
Medicine | 1 | 2024 | 942 | 0.120 |
Why?
|
Mycobacterium tuberculosis | 3 | 2016 | 1917 | 0.120 |
Why?
|
Macrophage Activation | 2 | 2016 | 552 | 0.120 |
Why?
|
Cross-Priming | 1 | 2015 | 75 | 0.120 |
Why?
|
Influenza Vaccines | 1 | 2022 | 778 | 0.120 |
Why?
|
Antibodies, Neutralizing | 2 | 2023 | 2010 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2022 | 8611 | 0.110 |
Why?
|
Toll-Like Receptor 3 | 1 | 2014 | 98 | 0.110 |
Why?
|
Monitoring, Physiologic | 1 | 2022 | 1792 | 0.110 |
Why?
|
Membrane Microdomains | 1 | 2015 | 203 | 0.110 |
Why?
|
Kidney Function Tests | 1 | 2016 | 683 | 0.110 |
Why?
|
Cytokines | 7 | 2021 | 7421 | 0.110 |
Why?
|
RNA, Double-Stranded | 1 | 2014 | 292 | 0.110 |
Why?
|
RNA, Viral | 1 | 2021 | 2864 | 0.110 |
Why?
|
Neurodegenerative Diseases | 1 | 2022 | 1087 | 0.100 |
Why?
|
Survival Analysis | 3 | 2021 | 10070 | 0.100 |
Why?
|
Viral Vaccines | 1 | 2018 | 597 | 0.100 |
Why?
|
Oligopeptides | 1 | 2018 | 1192 | 0.100 |
Why?
|
Cell Movement | 4 | 2022 | 5194 | 0.100 |
Why?
|
Sodium Chloride, Dietary | 1 | 2015 | 303 | 0.100 |
Why?
|
Dermatitis, Contact | 1 | 2013 | 135 | 0.100 |
Why?
|
Immediate-Early Proteins | 1 | 2015 | 444 | 0.100 |
Why?
|
Cells, Cultured | 5 | 2019 | 18973 | 0.100 |
Why?
|
Antigen Presentation | 2 | 2015 | 1250 | 0.100 |
Why?
|
Serine Endopeptidases | 1 | 2017 | 1024 | 0.090 |
Why?
|
Ovalbumin | 1 | 2013 | 674 | 0.090 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2233 | 0.090 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1811 | 0.090 |
Why?
|
Skin Neoplasms | 1 | 2010 | 5849 | 0.090 |
Why?
|
Humans | 31 | 2024 | 765968 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2020 | 1661 | 0.090 |
Why?
|
Leukocytes, Mononuclear | 1 | 2016 | 1857 | 0.080 |
Why?
|
Synovial Fluid | 1 | 2010 | 385 | 0.080 |
Why?
|
Multiple Organ Failure | 1 | 2011 | 390 | 0.080 |
Why?
|
Apoptosis | 4 | 2017 | 9514 | 0.070 |
Why?
|
Antibody Formation | 2 | 2023 | 1391 | 0.070 |
Why?
|
Adoptive Transfer | 1 | 2010 | 827 | 0.070 |
Why?
|
Phagocytosis | 3 | 2021 | 1520 | 0.070 |
Why?
|
Repressor Proteins | 1 | 2018 | 2968 | 0.070 |
Why?
|
Cell Line, Tumor | 4 | 2022 | 17075 | 0.070 |
Why?
|
Transgenes | 1 | 2010 | 1015 | 0.070 |
Why?
|
Protein Engineering | 1 | 2010 | 550 | 0.070 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2014 | 0.070 |
Why?
|
MicroRNAs | 1 | 2022 | 3785 | 0.070 |
Why?
|
Disease Models, Animal | 3 | 2021 | 18293 | 0.070 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1490 | 0.060 |
Why?
|
Down-Regulation | 1 | 2013 | 2927 | 0.060 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 2412 | 0.060 |
Why?
|
Mice, Transgenic | 2 | 2019 | 9550 | 0.060 |
Why?
|
Monocytes | 1 | 2014 | 2595 | 0.060 |
Why?
|
Female | 17 | 2022 | 396112 | 0.060 |
Why?
|
NF-kappa B | 3 | 2022 | 2485 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4044 | 0.060 |
Why?
|
Caspase 3 | 2 | 2017 | 731 | 0.060 |
Why?
|
Cell Proliferation | 1 | 2020 | 10429 | 0.060 |
Why?
|
Tumor Burden | 1 | 2010 | 1885 | 0.060 |
Why?
|
RNA, Messenger | 2 | 2021 | 12768 | 0.050 |
Why?
|
Signal Transduction | 7 | 2021 | 23601 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2020 | 6364 | 0.050 |
Why?
|
Untranslated Regions | 1 | 2022 | 30 | 0.050 |
Why?
|
Heat-Shock Response | 1 | 2024 | 179 | 0.050 |
Why?
|
Nucleocapsid | 1 | 2022 | 60 | 0.050 |
Why?
|
Neurons | 1 | 2021 | 9525 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2010 | 3737 | 0.050 |
Why?
|
Viral Structural Proteins | 1 | 2021 | 93 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2022 | 4642 | 0.050 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2022 | 126 | 0.050 |
Why?
|
Biology | 1 | 2024 | 293 | 0.050 |
Why?
|
Male | 15 | 2022 | 363698 | 0.050 |
Why?
|
Middle Aged | 10 | 2022 | 223009 | 0.050 |
Why?
|
Uridine Triphosphate | 1 | 2020 | 29 | 0.050 |
Why?
|
Chronic Disease | 2 | 2018 | 9347 | 0.040 |
Why?
|
Culture Media, Conditioned | 1 | 2022 | 522 | 0.040 |
Why?
|
Immune Tolerance | 2 | 2020 | 2324 | 0.040 |
Why?
|
Oxidative Stress | 2 | 2022 | 3141 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4247 | 0.040 |
Why?
|
Antilymphocyte Serum | 1 | 2022 | 493 | 0.040 |
Why?
|
Neutrophils | 1 | 2013 | 3776 | 0.040 |
Why?
|
Tuberculosis | 1 | 2013 | 2012 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2015 | 1240 | 0.040 |
Why?
|
Inflammation Mediators | 2 | 2021 | 1884 | 0.040 |
Why?
|
Lymphocyte Activation | 1 | 2010 | 5501 | 0.040 |
Why?
|
Germinal Center | 1 | 2022 | 379 | 0.040 |
Why?
|
Prognosis | 2 | 2019 | 29922 | 0.040 |
Why?
|
Antibodies, Blocking | 1 | 2019 | 249 | 0.040 |
Why?
|
Pilot Projects | 2 | 2023 | 8733 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39193 | 0.040 |
Why?
|
STAT5 Transcription Factor | 1 | 2019 | 269 | 0.040 |
Why?
|
Adult | 8 | 2022 | 223044 | 0.040 |
Why?
|
Retinal Dehydrogenase | 1 | 2018 | 78 | 0.040 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2020 | 284 | 0.040 |
Why?
|
Isoantibodies | 1 | 2022 | 681 | 0.040 |
Why?
|
Vaccines, Subunit | 1 | 2018 | 158 | 0.040 |
Why?
|
Brazil | 1 | 2021 | 1248 | 0.040 |
Why?
|
Vero Cells | 1 | 2018 | 481 | 0.030 |
Why?
|
Histocytochemistry | 1 | 2018 | 696 | 0.030 |
Why?
|
Sepsis | 1 | 2011 | 2606 | 0.030 |
Why?
|
Hospital Mortality | 1 | 2011 | 5343 | 0.030 |
Why?
|
Genotype | 3 | 2013 | 13024 | 0.030 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2022 | 975 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2013 | 16047 | 0.030 |
Why?
|
Serpins | 1 | 2017 | 245 | 0.030 |
Why?
|
Interleukins | 1 | 2020 | 791 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2022 | 1375 | 0.030 |
Why?
|
HEK293 Cells | 2 | 2015 | 4260 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2020 | 839 | 0.030 |
Why?
|
beta-N-Acetylhexosaminidases | 1 | 2014 | 43 | 0.030 |
Why?
|
Th17 Cells | 1 | 2021 | 786 | 0.030 |
Why?
|
Poly I-C | 1 | 2014 | 110 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2016 | 14448 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2417 | 0.030 |
Why?
|
Arginase | 1 | 2014 | 81 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 4108 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2020 | 1999 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2022 | 3602 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2020 | 3089 | 0.030 |
Why?
|
Bacterial Vaccines | 1 | 2016 | 400 | 0.030 |
Why?
|
Antioxidants | 1 | 2021 | 1670 | 0.030 |
Why?
|
Isoenzymes | 1 | 2018 | 1689 | 0.030 |
Why?
|
Croton Oil | 1 | 2013 | 2 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2022 | 2143 | 0.030 |
Why?
|
Purinergic P2X Receptor Antagonists | 1 | 2013 | 24 | 0.030 |
Why?
|
Virulence Factors | 1 | 2017 | 500 | 0.030 |
Why?
|
Clodronic Acid | 1 | 2013 | 60 | 0.030 |
Why?
|
Gene Frequency | 2 | 2011 | 3624 | 0.030 |
Why?
|
Th2 Cells | 1 | 2018 | 1075 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2017 | 1866 | 0.030 |
Why?
|
Lectins | 1 | 2014 | 487 | 0.030 |
Why?
|
Intestines | 1 | 2021 | 1906 | 0.020 |
Why?
|
Gene Expression | 2 | 2014 | 7584 | 0.020 |
Why?
|
Phenotype | 3 | 2016 | 16721 | 0.020 |
Why?
|
ROC Curve | 1 | 2019 | 3620 | 0.020 |
Why?
|
Species Specificity | 1 | 2016 | 2406 | 0.020 |
Why?
|
Hepatitis C, Chronic | 1 | 2020 | 1032 | 0.020 |
Why?
|
Autoimmunity | 1 | 2019 | 1354 | 0.020 |
Why?
|
Alleles | 1 | 2013 | 6897 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2020 | 2570 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2018 | 2721 | 0.020 |
Why?
|
Toll-Like Receptors | 1 | 2015 | 583 | 0.020 |
Why?
|
Bacteria | 1 | 2022 | 2209 | 0.020 |
Why?
|
Cell Line | 2 | 2017 | 15543 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 59889 | 0.020 |
Why?
|
Lymphocyte Count | 1 | 2013 | 790 | 0.020 |
Why?
|
Tissue Donors | 1 | 2020 | 2395 | 0.020 |
Why?
|
Aged | 5 | 2022 | 171117 | 0.020 |
Why?
|
Antibodies, Bacterial | 1 | 2016 | 1476 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5302 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2021 | 65188 | 0.020 |
Why?
|
Phosphorylation | 1 | 2020 | 8278 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3426 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4137 | 0.020 |
Why?
|
Child | 3 | 2022 | 80564 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 59489 | 0.020 |
Why?
|
Protein Transport | 1 | 2014 | 1939 | 0.020 |
Why?
|
HeLa Cells | 1 | 2015 | 3067 | 0.020 |
Why?
|
Risk Factors | 1 | 2016 | 74840 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2022 | 3896 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 42500 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 1995 | 0.020 |
Why?
|
DNA Damage | 1 | 2018 | 2457 | 0.020 |
Why?
|
Major Histocompatibility Complex | 1 | 2011 | 879 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7232 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4893 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4562 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1657 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2329 | 0.020 |
Why?
|
Lung | 2 | 2018 | 10033 | 0.020 |
Why?
|
Tetrazoles | 1 | 2013 | 920 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54802 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2013 | 1028 | 0.020 |
Why?
|
Swine | 1 | 2017 | 5988 | 0.020 |
Why?
|
Time Factors | 2 | 2021 | 40065 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6763 | 0.020 |
Why?
|
Pneumonia | 1 | 2018 | 2157 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2016 | 6493 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2013 | 1461 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2014 | 5881 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4353 | 0.010 |
Why?
|
Homozygote | 1 | 2009 | 1775 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 88835 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9525 | 0.010 |
Why?
|
Protein Binding | 1 | 2014 | 9296 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5753 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15880 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 11888 | 0.010 |
Why?
|
Pyridines | 1 | 2013 | 2888 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20124 | 0.010 |
Why?
|
Peptides | 1 | 2011 | 4331 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36386 | 0.010 |
Why?
|
Models, Biological | 1 | 2014 | 9443 | 0.010 |
Why?
|
Inflammation | 1 | 2016 | 10850 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2009 | 3800 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2011 | 15398 | 0.010 |
Why?
|
Age Factors | 1 | 2011 | 18380 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2011 | 11641 | 0.010 |
Why?
|
Aging | 1 | 2011 | 8731 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 81514 | 0.010 |
Why?
|
Cohort Studies | 1 | 2011 | 41649 | 0.000 |
Why?
|